Heidelberg Pharma AG's total assets for Q3 2025 were €54.05M, a decrease of -13.45% from the previous quarter. DE:HPHA total liabilities were €43.52M for the fiscal quarter, a -0.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.